# Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults

> **NCT06972212** · EARLY_PHASE1 · COMPLETED · sponsor: **Latigo Biotherapeutics** · enrollment: 20 (actual)

## Conditions studied

- Pain Detection
- Pain Threshold

## Interventions

- **DRUG:** suzetrigine 100mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06972212
- **Lead sponsor:** Latigo Biotherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-04
- **Primary completion:** 2025-06-28
- **Final completion:** 2025-06-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06972212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06972212, "Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06972212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*